Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Atrial Fibrillation | 29 | 2023 | 5180 | 1.890 |
Why?
|
Genome-Wide Association Study | 33 | 2025 | 12790 | 1.280 |
Why?
|
Genetic Predisposition to Disease | 24 | 2025 | 18063 | 0.980 |
Why?
|
Polymorphism, Single Nucleotide | 21 | 2025 | 16036 | 0.920 |
Why?
|
Genetic Variation | 11 | 2025 | 6611 | 0.880 |
Why?
|
Bradycardia | 2 | 2025 | 305 | 0.860 |
Why?
|
Tachycardia, Supraventricular | 1 | 2024 | 272 | 0.760 |
Why?
|
Electrocardiography | 8 | 2023 | 6409 | 0.650 |
Why?
|
Genetic Pleiotropy | 1 | 2018 | 181 | 0.550 |
Why?
|
Genetic Loci | 9 | 2022 | 2629 | 0.530 |
Why?
|
Epistasis, Genetic | 1 | 2017 | 353 | 0.490 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2018 | 541 | 0.480 |
Why?
|
Partial Thromboplastin Time | 1 | 2014 | 203 | 0.450 |
Why?
|
Stroke | 9 | 2023 | 9746 | 0.450 |
Why?
|
Hypertension | 5 | 2019 | 8615 | 0.430 |
Why?
|
Long QT Syndrome | 3 | 2022 | 473 | 0.420 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2014 | 425 | 0.390 |
Why?
|
Multifactorial Inheritance | 5 | 2024 | 1422 | 0.370 |
Why?
|
Fatty Acids, Omega-3 | 2 | 2018 | 1399 | 0.360 |
Why?
|
Atherosclerosis | 4 | 2023 | 3418 | 0.310 |
Why?
|
Biological Specimen Banks | 3 | 2024 | 787 | 0.310 |
Why?
|
Genetic Association Studies | 5 | 2020 | 2744 | 0.300 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2018 | 1250 | 0.300 |
Why?
|
Folic Acid Deficiency | 1 | 2008 | 117 | 0.290 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2024 | 843 | 0.280 |
Why?
|
Arrhythmias, Cardiac | 4 | 2022 | 2257 | 0.280 |
Why?
|
Sex Characteristics | 1 | 2017 | 2647 | 0.270 |
Why?
|
Lipids | 1 | 2018 | 3322 | 0.270 |
Why?
|
Models, Cardiovascular | 2 | 2022 | 978 | 0.270 |
Why?
|
Risk Factors | 26 | 2023 | 74886 | 0.270 |
Why?
|
Cardiomyopathies | 3 | 2023 | 2057 | 0.260 |
Why?
|
Aorta | 2 | 2024 | 2045 | 0.250 |
Why?
|
Protein C | 2 | 2017 | 134 | 0.250 |
Why?
|
Homocysteine | 1 | 2008 | 637 | 0.250 |
Why?
|
Brain Ischemia | 3 | 2020 | 3001 | 0.240 |
Why?
|
Sick Sinus Syndrome | 1 | 2025 | 51 | 0.240 |
Why?
|
Homeodomain Proteins | 3 | 2020 | 2429 | 0.240 |
Why?
|
Feeding Behavior | 2 | 2013 | 3207 | 0.210 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 1 | 2024 | 148 | 0.210 |
Why?
|
Endophenotypes | 2 | 2022 | 258 | 0.210 |
Why?
|
Quantitative Trait Loci | 6 | 2021 | 2131 | 0.210 |
Why?
|
Middle Aged | 37 | 2024 | 223233 | 0.210 |
Why?
|
Diet | 2 | 2013 | 8089 | 0.210 |
Why?
|
Heterozygote | 4 | 2022 | 2794 | 0.200 |
Why?
|
Humans | 69 | 2025 | 767040 | 0.200 |
Why?
|
Risk Assessment | 11 | 2024 | 24299 | 0.200 |
Why?
|
Male | 43 | 2025 | 364203 | 0.190 |
Why?
|
Folic Acid | 1 | 2008 | 1336 | 0.190 |
Why?
|
Female | 44 | 2025 | 396660 | 0.180 |
Why?
|
Cardiovascular Diseases | 5 | 2023 | 15645 | 0.180 |
Why?
|
Myocardial Infarction | 2 | 2023 | 11513 | 0.180 |
Why?
|
Aortic Aneurysm | 2 | 2022 | 649 | 0.180 |
Why?
|
Aged | 30 | 2024 | 171319 | 0.170 |
Why?
|
Mitral Valve Prolapse | 1 | 2022 | 213 | 0.170 |
Why?
|
Cardiac Myosins | 1 | 2020 | 128 | 0.170 |
Why?
|
Body Mass Index | 1 | 2017 | 13048 | 0.160 |
Why?
|
Chromosomes, Human, Pair 4 | 2 | 2017 | 377 | 0.160 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2021 | 325 | 0.160 |
Why?
|
Anticoagulants | 4 | 2020 | 4854 | 0.160 |
Why?
|
Mendelian Randomization Analysis | 3 | 2024 | 1040 | 0.160 |
Why?
|
beta-Globins | 1 | 2019 | 111 | 0.160 |
Why?
|
Aorta, Thoracic | 2 | 2024 | 1110 | 0.160 |
Why?
|
Pacemaker, Artificial | 1 | 2025 | 828 | 0.160 |
Why?
|
Myosin Heavy Chains | 1 | 2020 | 403 | 0.160 |
Why?
|
Blood Pressure | 2 | 2019 | 8531 | 0.160 |
Why?
|
Linkage Disequilibrium | 3 | 2019 | 1996 | 0.150 |
Why?
|
Coronary Artery Disease | 3 | 2023 | 6573 | 0.150 |
Why?
|
Cholesterol, LDL | 2 | 2018 | 2392 | 0.150 |
Why?
|
Electronic Prescribing | 1 | 2018 | 115 | 0.140 |
Why?
|
Gene Frequency | 3 | 2019 | 3621 | 0.130 |
Why?
|
Transcription Factor AP-2 | 1 | 2016 | 78 | 0.130 |
Why?
|
Death, Sudden, Cardiac | 2 | 2022 | 1567 | 0.130 |
Why?
|
Incidence | 9 | 2021 | 21526 | 0.130 |
Why?
|
Health Services Misuse | 1 | 2018 | 246 | 0.130 |
Why?
|
Myocytes, Cardiac | 3 | 2024 | 1672 | 0.130 |
Why?
|
Community-Based Participatory Research | 1 | 2017 | 223 | 0.130 |
Why?
|
Hemostatics | 1 | 2018 | 247 | 0.120 |
Why?
|
Kininogens | 1 | 2014 | 15 | 0.120 |
Why?
|
Case-Control Studies | 6 | 2024 | 22254 | 0.120 |
Why?
|
Neural Cell Adhesion Molecule L1 | 1 | 2014 | 44 | 0.120 |
Why?
|
Life Style | 4 | 2018 | 3931 | 0.110 |
Why?
|
Phenotype | 5 | 2025 | 16718 | 0.110 |
Why?
|
Hemostasis | 1 | 2017 | 467 | 0.110 |
Why?
|
Embolism | 1 | 2017 | 401 | 0.110 |
Why?
|
Factor V | 1 | 2014 | 168 | 0.110 |
Why?
|
Age Factors | 6 | 2021 | 18401 | 0.110 |
Why?
|
Gallstones | 1 | 2016 | 285 | 0.110 |
Why?
|
Action Potentials | 2 | 2018 | 1835 | 0.110 |
Why?
|
Triglycerides | 2 | 2018 | 2444 | 0.110 |
Why?
|
Medical Order Entry Systems | 1 | 2018 | 523 | 0.100 |
Why?
|
Factor VIII | 1 | 2015 | 349 | 0.100 |
Why?
|
Follow-Up Studies | 5 | 2020 | 39317 | 0.100 |
Why?
|
Genetic Markers | 2 | 2017 | 2602 | 0.100 |
Why?
|
Cholesterol | 2 | 2018 | 2905 | 0.100 |
Why?
|
Causality | 1 | 2018 | 1253 | 0.100 |
Why?
|
Aged, 80 and over | 10 | 2020 | 59548 | 0.100 |
Why?
|
Cholesterol, HDL | 1 | 2018 | 1816 | 0.090 |
Why?
|
Models, Genetic | 1 | 2021 | 3445 | 0.090 |
Why?
|
Diabetes Complications | 1 | 2018 | 1319 | 0.090 |
Why?
|
Microfilament Proteins | 1 | 2016 | 1130 | 0.090 |
Why?
|
von Willebrand Factor | 1 | 2015 | 680 | 0.090 |
Why?
|
Nuts | 1 | 2013 | 264 | 0.090 |
Why?
|
Longitudinal Studies | 4 | 2023 | 14766 | 0.090 |
Why?
|
Fibrinogen | 1 | 2014 | 892 | 0.090 |
Why?
|
Dyslipidemias | 1 | 2018 | 872 | 0.090 |
Why?
|
Odds Ratio | 3 | 2017 | 9660 | 0.090 |
Why?
|
Meat | 1 | 2013 | 588 | 0.090 |
Why?
|
Parathyroid Hormone | 1 | 2016 | 1804 | 0.090 |
Why?
|
Dairy Products | 1 | 2013 | 490 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2017 | 3797 | 0.080 |
Why?
|
Disease Management | 1 | 2020 | 2531 | 0.080 |
Why?
|
Membrane Transport Proteins | 1 | 2015 | 1029 | 0.080 |
Why?
|
Heart Diseases | 1 | 2022 | 2817 | 0.080 |
Why?
|
Adult | 16 | 2024 | 223317 | 0.080 |
Why?
|
Transcription Factors | 2 | 2020 | 12158 | 0.080 |
Why?
|
Genotype | 4 | 2017 | 13035 | 0.080 |
Why?
|
Hyperhomocysteinemia | 1 | 2008 | 117 | 0.070 |
Why?
|
Guideline Adherence | 1 | 2018 | 2232 | 0.070 |
Why?
|
Antihypertensive Agents | 1 | 2017 | 2030 | 0.070 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2023 | 3249 | 0.070 |
Why?
|
Genome, Human | 1 | 2021 | 4441 | 0.070 |
Why?
|
Alcohol Drinking | 1 | 2020 | 4045 | 0.070 |
Why?
|
Taiwan | 1 | 2008 | 521 | 0.070 |
Why?
|
Sampling Studies | 1 | 2008 | 614 | 0.070 |
Why?
|
Nutritional Requirements | 1 | 2008 | 279 | 0.070 |
Why?
|
Quality Control | 2 | 2021 | 835 | 0.070 |
Why?
|
Fatty Acids | 1 | 2014 | 1806 | 0.070 |
Why?
|
Hemorrhage | 1 | 2018 | 3464 | 0.060 |
Why?
|
Electronic Health Records | 2 | 2020 | 4881 | 0.060 |
Why?
|
Micronutrients | 1 | 2008 | 390 | 0.060 |
Why?
|
Heart Defects, Congenital | 1 | 2022 | 4713 | 0.060 |
Why?
|
Venous Thromboembolism | 2 | 2015 | 1883 | 0.060 |
Why?
|
Genomics | 1 | 2021 | 5924 | 0.060 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2021 | 8940 | 0.060 |
Why?
|
Membrane Glycoproteins | 1 | 2015 | 3702 | 0.060 |
Why?
|
United States | 7 | 2021 | 72971 | 0.060 |
Why?
|
Age of Onset | 2 | 2022 | 3344 | 0.050 |
Why?
|
Blood Proteins | 1 | 2008 | 1190 | 0.050 |
Why?
|
Cohort Studies | 4 | 2023 | 41718 | 0.050 |
Why?
|
Proportional Hazards Models | 2 | 2019 | 12536 | 0.050 |
Why?
|
Dilatation, Pathologic | 1 | 2024 | 527 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7435 | 0.050 |
Why?
|
Databases, Genetic | 2 | 2019 | 1758 | 0.050 |
Why?
|
Latent TGF-beta Binding Proteins | 1 | 2022 | 45 | 0.050 |
Why?
|
Nuclear Localization Signals | 1 | 2022 | 78 | 0.050 |
Why?
|
Body Weights and Measures | 1 | 2022 | 208 | 0.050 |
Why?
|
Lamin Type A | 1 | 2022 | 187 | 0.050 |
Why?
|
Massachusetts | 3 | 2020 | 8890 | 0.050 |
Why?
|
Myocardium | 2 | 2024 | 4765 | 0.050 |
Why?
|
Cytochrome P-450 CYP2D6 | 1 | 2021 | 108 | 0.040 |
Why?
|
Prospective Studies | 4 | 2021 | 54886 | 0.040 |
Why?
|
Population Density | 1 | 2021 | 193 | 0.040 |
Why?
|
Proteins | 1 | 2014 | 6001 | 0.040 |
Why?
|
INDEL Mutation | 1 | 2021 | 266 | 0.040 |
Why?
|
Administration, Oral | 2 | 2018 | 4026 | 0.040 |
Why?
|
Heart | 2 | 2023 | 4429 | 0.040 |
Why?
|
Reproducibility of Results | 1 | 2017 | 20169 | 0.040 |
Why?
|
Algorithms | 1 | 2020 | 14098 | 0.040 |
Why?
|
Disease | 1 | 2024 | 675 | 0.040 |
Why?
|
Gene Expression Regulation | 1 | 2016 | 11923 | 0.040 |
Why?
|
Heart Failure | 2 | 2020 | 11877 | 0.040 |
Why?
|
Virulence | 1 | 2022 | 1294 | 0.040 |
Why?
|
Ventricular Function, Right | 1 | 2022 | 629 | 0.040 |
Why?
|
Caveolin 2 | 1 | 2017 | 25 | 0.040 |
Why?
|
Penetrance | 1 | 2019 | 388 | 0.040 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2022 | 12250 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 2 | 2022 | 36582 | 0.040 |
Why?
|
Sample Size | 1 | 2021 | 845 | 0.040 |
Why?
|
Mutagenesis | 1 | 2021 | 1227 | 0.030 |
Why?
|
Predictive Value of Tests | 2 | 2023 | 15424 | 0.030 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2022 | 707 | 0.030 |
Why?
|
Fibrosis | 1 | 2023 | 2078 | 0.030 |
Why?
|
Sex Factors | 2 | 2020 | 10622 | 0.030 |
Why?
|
Magnetic Resonance Imaging, Cine | 1 | 2023 | 1092 | 0.030 |
Why?
|
Caveolin 1 | 1 | 2017 | 255 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2022 | 1791 | 0.030 |
Why?
|
Methionine Adenosyltransferase | 1 | 2015 | 16 | 0.030 |
Why?
|
Deoxyribonucleases | 1 | 2016 | 209 | 0.030 |
Why?
|
Zebrafish | 2 | 2017 | 3036 | 0.030 |
Why?
|
Primary Prevention | 1 | 2023 | 1188 | 0.030 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2017 | 301 | 0.030 |
Why?
|
Genetics, Population | 1 | 2019 | 943 | 0.030 |
Why?
|
T-Box Domain Proteins | 1 | 2017 | 471 | 0.030 |
Why?
|
Haplotypes | 1 | 2021 | 2722 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2017 | 640 | 0.030 |
Why?
|
Hyperlipidemias | 1 | 2019 | 771 | 0.030 |
Why?
|
Hypothyroidism | 1 | 2019 | 667 | 0.030 |
Why?
|
Comorbidity | 2 | 2020 | 10582 | 0.030 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2018 | 792 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2016 | 1160 | 0.030 |
Why?
|
Body Height | 1 | 2019 | 1565 | 0.030 |
Why?
|
Alleles | 2 | 2016 | 6893 | 0.030 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2023 | 3684 | 0.030 |
Why?
|
Heart Conduction System | 1 | 2018 | 1008 | 0.030 |
Why?
|
Young Adult | 2 | 2023 | 59980 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2017 | 1562 | 0.030 |
Why?
|
Cadherins | 1 | 2017 | 903 | 0.020 |
Why?
|
Prevalence | 2 | 2020 | 15851 | 0.020 |
Why?
|
Heart Valve Diseases | 1 | 2019 | 1029 | 0.020 |
Why?
|
Heart Atria | 1 | 2017 | 1362 | 0.020 |
Why?
|
Mammals | 1 | 2016 | 1135 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1366 | 0.020 |
Why?
|
Echocardiography | 1 | 2022 | 5042 | 0.020 |
Why?
|
Europe | 1 | 2016 | 3432 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2020 | 6844 | 0.020 |
Why?
|
Genetic Testing | 1 | 2022 | 3591 | 0.020 |
Why?
|
Body Weight | 1 | 2019 | 4627 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2022 | 4925 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2023 | 2666 | 0.020 |
Why?
|
Proteomics | 1 | 2022 | 3913 | 0.020 |
Why?
|
Stroke Volume | 1 | 2022 | 5618 | 0.020 |
Why?
|
Peripheral Arterial Disease | 1 | 2019 | 1304 | 0.020 |
Why?
|
Health Surveys | 1 | 2018 | 4056 | 0.020 |
Why?
|
Phosphoproteins | 1 | 2017 | 2448 | 0.020 |
Why?
|
Computational Biology | 1 | 2019 | 3567 | 0.020 |
Why?
|
Lipid Metabolism | 1 | 2016 | 1895 | 0.020 |
Why?
|
Gene Expression | 1 | 2020 | 7587 | 0.020 |
Why?
|
Recurrence | 1 | 2020 | 8504 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 40154 | 0.020 |
Why?
|
Health Status | 1 | 2020 | 4091 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2011 | 800 | 0.020 |
Why?
|
Heart Rate | 1 | 2018 | 4209 | 0.020 |
Why?
|
Histones | 1 | 2016 | 2597 | 0.020 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2018 | 2764 | 0.020 |
Why?
|
Survival Rate | 1 | 2020 | 12823 | 0.020 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2019 | 2299 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2017 | 10748 | 0.020 |
Why?
|
Coronary Disease | 1 | 2019 | 5914 | 0.020 |
Why?
|
Databases, Factual | 1 | 2020 | 8068 | 0.010 |
Why?
|
Exercise | 1 | 2021 | 5954 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3667 | 0.010 |
Why?
|
Cell Line | 1 | 2017 | 15567 | 0.010 |
Why?
|
Smoking | 1 | 2019 | 9081 | 0.010 |
Why?
|
Quality Improvement | 1 | 2018 | 3854 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9606 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2020 | 5363 | 0.010 |
Why?
|
Registries | 1 | 2018 | 8351 | 0.010 |
Why?
|
Logistic Models | 1 | 2016 | 13284 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2022 | 81659 | 0.010 |
Why?
|
Gene Expression Profiling | 1 | 2017 | 9532 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20741 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2020 | 26325 | 0.010 |
Why?
|
Animals | 2 | 2017 | 168965 | 0.010 |
Why?
|
Mice | 1 | 2017 | 81912 | 0.010 |
Why?
|